Source: San Diego Business Journal

Amplyx Pharmaceuticals: Amplyx Pharmaceuticals Snags FDA Orphan Drug Designation

San Diego-based Amplyx Pharmaceuticals' lead drug candidate received an orphan drug designation for a condition that can be life-threatening for HIV/AIDs patients and others.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Ciara Kennedy's photo - President & CEO of Amplyx

President & CEO

Ciara Kennedy

CEO Approval Rating

89/100

Amplyx is a biotechnology company that researches, develops and commercializes novel therapeutics for the treatment of fungal infections. Read more